Norway· NO-ID_D2935270-2AA0-4334-99E8-42AE64A5C795

Gasprid

A cisapride product containing cisapride, registered in Norway by Teva. The same ATC class is registered in 4 of our 19 countries.

ATC A03FA02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedGaspridATCA03FA02REGISTER NO.NO-ID_D2935270-2AA0-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Cisapride is registered in 4 of 19 countries.

Countries holding a registration under ATC A03FA02 (cisapride), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 3 of them publish a price we can compare per daily dose

Cisapride · ATC A03FA02

4 / 19 countries

  • Finlandprice
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Cisapride
Manufacturer
Teva
Country
Norway (NO)
ATC code
A03FA02
ATC class
Cisapride
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_D2935270-2AA0-4334-99E8-42AE64A5C795
  • no_varenummer
    249939
    30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

367 interactions on record for cisapride.

Graded by severity as the source publishes them — 276 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cisapride · interactions on record

367 records

  • 276 severe
  • 85 moderate
  • 6 minor

Most severe, free to view

  • CimetidineA02BA01severe
  • PapaverineA03AD01severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cisapride in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cisapride products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Poland · Gasprid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cde2c7e1-68b9-4d27-8a62-453761d3e10c
GET /v1/drugs/cde2c7e1-68b9-4d27-8a62-453761d3e10c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Cisaprid",
  "merkevare_id": "ID_D2935270-2AA0-4334-99E8-42AE64A5C795",
  "name_form_strength": "Gasprid tab 5 mg",
  "prescription_group": "C"
}

See everything about cisapride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.